COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,749 Articles (22,502 medRxiv, 8,247 bioRxiv)

Most recent first Previous |  Page 129: Articles 1281-1290  | Next

The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O'Leary, P. C., Taha, T. Y., Zapatero-Belinchon, F. J., McCavitt-Malvido, M., Doruk, Y. U., Stevens, M. G. V., Diolati, M. E., Jogalekar, M. P., Richards, A. L., Montano, M., Rosecrans, J., Matthay, M., Togo, T., Gonciarz, R. L., Gopalkrishnan, S., Neitz, R. J., Krogan, N. J., Swaney, D. L., Shoichet, B. K., Ott, M., Renslo, A. R., Ashworth, A., Fraser, J. S.
10.1101/2024.08.08.606661 — Posted: 2024-08-09
SARS-COV-2 nucleocapsid protein hijacks multiple components of the host nuclear transport machinery for distinct functions
Harrison, A. R., Wang, S. Z., Wagstaff, K. M.
10.1101/2024.08.09.607288 — Posted: 2024-08-09
Extraction-free colorimetric RT-LAMP for SARS-CoV-2 RNA detection from saliva
Yang, Y., Liu, X., Tie, S., Li, X., Yang, X., Cao, J.
10.1101/2024.08.09.607279 — Posted: 2024-08-09
LGM: Novel large empirical study of deep transfer learning for COVID-19 classification based on CT and X-ray images
Almutaani, M., Turki, T., Taguchi, Y.-h.
10.1101/2024.08.08.24311683 — Posted: 2024-08-09
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rubio, R., Yavlinsky, A., Escalera Zamudio, M., Molinos-Albert, L. M., Martin Perez, C., Pradenas, E., Canyelles, M., Torres, C., Tan, C., Swadling, L., Ramirez-Morros, A., Trinite, B., Vidal-Alaball, J., Aguilar, R., Ruiz-Comellas, A., Blanco, J., van Dorp, L., Balloux, F., Dobano, C., Moncunill, G.
10.1101/2024.08.09.24311705 — Posted: 2024-08-09
Combining short and long read sequencing technologies to identify SARS-CoV-2 variants in wastewater
Jayme, G., Liu, J.-L., Galvez, J. H., Reiling, S. J., Aydin, S. C., N'Guessan, A., Lee, S., Chen, S.-H., Tsitouras, A., Sanchez-Quete, F., Maere, T., Goitom, E., Hachad, M., Mercier, E., Loeb, S. K., Vanrolleghem, P., Dorner, S., Delatolla, R., Shapiro, B. J., Frigon, D., Ragoussis, J., Snutch, T. P.
10.1101/2024.08.07.24311639 — Posted: 2024-08-08
Effectiveness of digital health interventions against COVID-19 misinformation: a systematic realist review of intervention trials
Dickinson, R., Makowski, D., van Marwijk, H., Ford, E.
10.1101/2024.08.07.24311635 — Posted: 2024-08-08
The role of a structured community health worker network in achieving malaria elimination goals in the Dominican Republic: an impact evaluation amid COVID-19 disruptions
Michelen Strofer, N., Tejada Bueno, N., Santos Felix, M. Y., Cruz Raposo, J. L., Lana, J. T., Turbe, V., Cohen, J. M., Napier, H. G.
10.1101/2024.08.07.24311633 — Posted: 2024-08-08
Hydrogen Sulfide (H2S)-Producing Oral Bacteria May Protect Against COVID-19
Vaishnani, M., Modi, A., Chauhan, k., Parekh, B.
10.1101/2024.08.07.24311606 — Posted: 2024-08-08
Novel dPCR-Based Approach for SARS-CoV-2 Variant Detection and Monitoring in Wastewater: A Multi-State Comparison with Clinical Genotyping and GISAID Sequencing Data
Acer, P., Andersen, P., Barbero, R., Barksdale, S., Bellakbira, S., Bunde, D., Dunlap, R., Erickson, J., Goldfarb, D., Jones-Roe, T., Kilroy, M., Le, H., Lepene, B., Milich, E., Mohamed, A., Mosavi, S., Munns, D., Obermeyer, J., Patnaik, A., Pricer, G., Reven, M., Richardson, D., Ruhunusiri, C., Saswata, S., Saunders, L. P., Swahn, O., Vengurlekar, K., White, D., Lozach, J., Flores-Baffi, A. P., Easton, F., Dahlke, M., Fang, A., Cibin, D., Wesselman, T., Sablon, O., Wolfe, M., Liu, P., Hilton, S., Wang, Y., Moe, C. L., Kashwala, S., Camarato, E., Shrestha, S., Wied, R., Roguet, A., Janssen, K.
10.1101/2024.08.07.24311627 — Posted: 2024-08-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).